These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33716385)

  • 1. Disentangling Moral Hazard and Adverse Selection in Private Health Insurance.
    Powell D; Goldman D
    J Econom; 2021 May; 222(1):141-160. PubMed ID: 33716385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection on Moral Hazard in Health Insurance.
    Einav L; Finkelstein A; Ryan S; Schrimpf P; Cullen MR
    Am Econ Rev; 2013 Feb; 103(1):178-219. PubMed ID: 24748682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for selection bias and moral hazard in private health insurance: Evidence from a mixed public-private health system.
    Afoakwah C; Byrnes J; Scuffham P; Nghiem S
    Health Econ; 2023 Jan; 32(1):3-24. PubMed ID: 36100982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk selection and heterogeneous preferences in health insurance markets with a public option.
    Polyakova M
    J Health Econ; 2016 Sep; 49():153-68. PubMed ID: 27454199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse selection, moral hazard, and wealth effects in the Medigap insurance market.
    Wolfe JR; Goddeeris JH
    J Health Econ; 1991; 10(4):433-59. PubMed ID: 10117013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric Information in Iranian's Health Insurance Market: Testing of Adverse Selection and Moral Hazard.
    Lotfi F; Abolghasem Gorji H; Mahdavi G; Hadian M
    Glob J Health Sci; 2015 Apr; 7(6):146-55. PubMed ID: 26153155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the causal effects of private health insurance in Brazil: Evidence from a regression kink design.
    Menezes-Filho N; Politi R
    Soc Sci Med; 2020 Nov; 264():113258. PubMed ID: 32854067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering health insurance through informal financial groups: Evidence on moral hazard and adverse selection.
    Sheth K
    Health Econ; 2021 Sep; 30(9):2185-2199. PubMed ID: 34114717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which moral hazard? Health care reform under the Affordable Care Act of 2010.
    Mendoza RL
    J Health Organ Manag; 2016 Jun; 30(4):510-29. PubMed ID: 27296875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse selection and the challenges to stand-alone prescription drug insurance.
    Pauly MV; Zeng Y
    Front Health Policy Res; 2004; 7():55-74. PubMed ID: 15612335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplemental Health Insurance and Healthcare Consumption-A Dynamic Approach to Moral Hazard.
    Franc C; Perronnin M; Pierre A
    Health Econ; 2016 Dec; 25(12):1582-1598. PubMed ID: 26468078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
    Mendoza RL
    J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MORAL HAZARD IN HEALTH INSURANCE: DO DYNAMIC INCENTIVES MATTER?
    Aron-Dine A; Einav L; Finkelstein A; Cullen M
    Rev Econ Stat; 2015 Oct; 97(4):725-741. PubMed ID: 26769985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moral hazard matters: measuring relative rates of underinsurance using threshold measures.
    Abraham JM; Deleire T; Royalty AB
    Health Serv Res; 2010 Jun; 45(3):806-24. PubMed ID: 20337736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model to decompose the performance of supplementary private health insurance markets.
    Leidl R
    Int J Health Care Finance Econ; 2008 Sep; 8(3):193-208. PubMed ID: 18568435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing risk adjustment and free health plan choice in employer-based health insurance: Evidence from Germany.
    Pilny A; Wübker A; Ziebarth NR
    J Health Econ; 2017 Dec; 56():330-351. PubMed ID: 29248059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decomposition of moral hazard.
    Nyman JA; Koc C; Dowd BE; McCreedy E; Trenz HM
    J Health Econ; 2018 Jan; 57():168-178. PubMed ID: 29275240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions in insurance for mental disorders: adverse selection, moral hazard, and consumer demand.
    Sharfstein SS; Taube CA
    Am J Psychiatry; 1982 Nov; 139(11):1425-30. PubMed ID: 7137391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The magnitude and nature of risk selection in employer-sponsored health plans.
    Nicholson S; Bundorf K; Stein RM; Polsky D
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1817-38. PubMed ID: 15533189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How will changes in health insurance tax policy and employer health plan contributions affect access to health care and health care costs?
    Marquis MS; Buchanan JL
    JAMA; 1994 Mar 23-30; 271(12):939-44. PubMed ID: 8120964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.